Gil Y. Melmed, MD

​

Director, Clinical Inflammatory Bowel Disease

Director, Advanced Inflammatory Bowel Disease Fellowship Program

Director, Clinical Research in the Division of Gastroenterology

Cedar-Sinai Medical Center

Los Angeles, California

​

Gil Y. Melmed, MD, MS, is the Co-Director of the Inflammatory Bowel Disease Center at Cedars-Sinai Medical Center in Los Angeles, California. He earned his medical degree from Albert Einstein College of Medicine in the Bronx, New York, and master of science in clinical research from UCLA School of Medicine, Los Angeles. Dr Melmed completed his gastroenterology fellowship at the University of California, Los Angeles. 

 

He has authored or coauthored more than 130 articles in peer-reviewed journals and several book chapters. Dr Melmed is an Associate Editor of the American Journal of Gastroenterology, an ad hoc reviewer for several journals, and previously a clinical research editor for Inflammatory Bowel Disease. His research interests include clinical outcomes and quality of care in IBD. He has given more than 100 invited lectures and presentations nationally and internationally. He is a committee member of several professional organizations, including the American College of Gastroenterology and the Crohn’s and Colitis Foundation, where he serves as co-chair of the IBD Quality of Care committee. He has led or participated in the development of quality measures for IBD with the American Gastroenterology Association, the Crohn’s and Colitis Foundation, and the Canadian Crohn’s and Colitis organizations.

 

Speaker Disclosure Statement:

Gil Y. Melmed, MD, has disclosed that he has served as a consultant for and has participated on the advisory boards for AbbVie, Celgene, Janssen, Medtronic, Pfizer, RedHill, Samsung and Takeda. He has received research support from Pfizer.